Elevance Health Inc. (ANTM)

8 members of Congress have disclosed 28 trades in Elevance Health Inc. (ANTM) via STOCK Act filings. The most recent disclosure was a sale by John Curtis on 9 March 2022. The most active traders have been John Curtis (9), Lizzie Fletcher (6), and Joe Courtney (4). Aggregate disclosed activity totals roughly $120K in purchases and $279K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ANTM
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ANTM

5 transactions
Compliance: 54%
John Curtis9 Mar 20227 Aug 2023SaleStock$1,001 - $15,000N/A
John Curtis9 Mar 202223 Mar 2022SaleStock$1,001 - $15,000N/A
John Curtis9 Mar 202211 Aug 2023SaleStock$1,001 - $15,000N/A
Diana Harshbarger28 Jan 2022StockN/A
John Curtis14 Jan 202211 Aug 2023PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$114.59B

Volume

1.27M

Beta

0.97

P/E Ratio

18.99

Fundamentals

EPS

$25.41

Div. Yield

1.00%

Open

$469.53

Day Range

$466.74 – $485.75

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Plans
Exchange
NYSE · USD
Country
US
CEO
Gail Boudreaux
IPO Date
2001-10-30
Website
www.elevancehealth.com

Anthem, Inc. is a U.S.-based health benefits corporation that operates through its various subsidiary companies. Its operations are structured across four main divisions: Commercial & Specialty Business, Government Business, IngenioRx, and a general...

Earnings

Recent Quarters

Q2 202220 Jul
EPS$6.78
Miss 12.2%
Q1 202220 Apr
EPS$8.25
Beat 5.6%
Q4 202126 Jan
EPS$5.14
Beat 0.6%
Q3 202120 Oct
EPS$6.79
Beat 6.6%
Q2 202121 Jul
EPS$7.03
Beat 11.1%
Q1 202121 Apr
EPS$7.01
Beat 7.7%
Q4 202027 Jan
EPS$2.54
Beat 0.8%
Q3 202028 Oct
EPS$4.20
Beat 1.2%
Q2 202029 Jul
EPS$9.20
Beat 3.6%
Q1 202029 Apr
EPS$6.48
Beat 0.0%
Q4 201929 Jan
EPS$3.88
Beat 0.0%
Q3 201923 Oct
EPS$4.87
Beat 1.0%
Q2 201924 Jul
EPS$4.64
Beat 0.7%
Q1 201924 Apr
EPS$6.03
Beat 3.8%
Q4 201830 Jan
EPS$2.44
Beat 10.9%
Q3 201831 Oct
EPS$3.81
Beat 3.0%
Q2 201825 Jul
EPS$4.25
Beat 2.2%
Q1 201825 Apr
EPS$5.41
Beat 10.9%
Q4 201731 Jan
EPS$1.29
Beat 1.6%
Q3 201725 Oct
EPS$2.65
Beat 9.5%
Q2 201726 Jul
EPS$3.37
Beat 4.3%
Q1 201726 Apr
EPS$4.68
Beat 21.2%
Q4 20161 Feb
EPS$1.76
Beat 9.3%
Q3 20162 Nov
EPS$2.45
Miss 0.8%
Q2 201627 Jul
EPS$3.33
Beat 3.1%
Q1 201627 Apr
EPS$3.46
Beat 4.2%
Q4 201527 Jan
EPS$1.14
Miss 5.0%
Q3 201528 Oct
EPS$2.73
Beat 17.2%
Q2 201529 Jul
EPS$3.10
Beat 11.9%
Q1 201529 Apr
EPS$3.14
Beat 17.6%
Q4 201428 Jan
EPS$1.73
Beat 0.6%
Q3 201429 Oct
EPS$2.36
Beat 4.0%
Q2 201430 Jul
EPS$2.44
Beat 8.0%
Q1 201430 Apr
EPS$2.30
Beat 8.5%
Q4 201329 Jan
EPS$0.87
Beat 0.0%
Q3 201323 Oct
EPS$2.10
Beat 15.4%
Q2 201324 Jul
EPS$2.60
Beat 23.2%
Q1 201324 Apr
EPS$2.94
Beat 23.5%
Q4 201223 Jan
EPS$1.03
Beat 8.4%
Q3 20127 Nov
EPS$2.09
Beat 13.6%
Q2 201225 Jul
EPS$2.04
Miss 1.9%
Q1 201225 Apr
EPS$2.34
Beat 3.1%
Q4 201125 Jan
EPS$0.99
Miss 11.6%
Q3 201126 Oct
EPS$1.77
Beat 5.4%
Q2 201127 Jul
EPS$1.83
Beat 1.7%
Q1 201127 Apr
EPS$2.35
Beat 25.7%
Q4 201026 Jan
EPS$1.33
Beat 8.1%
Q3 20103 Nov
EPS$1.74
Beat 10.1%
Q2 201028 Jul
EPS$1.67
Beat 7.7%
Q1 201028 Apr
EPS$1.95
Beat 16.8%
Q4 200927 Jan
EPS$1.16
Beat 13.7%
Q3 200928 Oct
EPS$1.78
Beat 29.9%
Q2 200929 Jul
EPS$1.50
Beat 4.9%
Q1 200922 Apr
EPS$1.62
Beat 29.6%
Q4 200828 Jan
EPS$0.65
Miss 52.2%
Q3 200822 Oct
EPS$1.60
Beat 7.4%
Q2 200823 Jul
EPS$1.44
Beat 5.9%
Q1 200823 Apr
EPS$1.07
Miss 10.1%
Q4 200723 Jan
EPS$1.51
Beat 0.0%
Q3 200724 Oct
EPS$1.45
Beat 0.7%
Q2 200725 Jul
EPS$1.35
Beat 0.0%
Q1 200725 Apr
EPS$1.26
Beat 0.0%
Q4 200624 Jan
EPS$1.27
Beat 0.0%
Q3 200625 Oct
EPS$1.24
Beat 0.8%
Q2 200626 Jul
EPS$1.18
Beat 3.5%
Q1 200626 Apr
EPS$1.10
Beat 2.8%
Q4 200525 Jan
EPS$1.05
Beat 1.0%
Q3 200526 Oct
EPS$1.02
Beat 1.0%
Q2 200527 Jul
EPS$1.00
Beat 3.1%
Q1 200527 Apr
EPS$0.94
Beat 3.3%
Q4 20047 Feb
EPS$0.85
Beat 1.2%
Q3 200427 Oct
EPS$0.84
Beat 1.2%
Q2 200427 Jul
EPS$0.83
Beat 1.2%
Q1 200428 Apr
EPS$0.81
Beat 11.0%
Q4 200329 Jan
EPS$0.72
Beat 4.3%
Q3 200327 Oct
EPS$0.68
Beat 3.0%
Q2 200331 Jul
EPS$0.65
Beat 4.8%
Q1 200330 Apr
EPS$0.59
Beat 0.0%
Q4 20022 Feb
EPS$0.56
Beat 1.8%
Q3 20024 Nov
EPS$0.53
Beat 6.0%
Q2 20025 Aug
EPS$0.50
Beat 2.0%
Q1 200229 Apr
EPS$0.47
Beat 11.9%
Q4 20016 Feb
EPS$0.48
Beat 6.7%
Q2 200130 Sept
EPS$0.54

11 politicians traded within 30 days

Dividends

Dividend History

10 Sept 2026
Amount $1.7200
10 Jun 2026
Amount $1.7200
10 Mar 2026
Amount $1.7200
5 Dec 2025
Amount $1.7100
10 Sept 2025
Amount $1.7100
10 Jun 2025
Amount $1.7100
10 Mar 2025
Amount $1.7100
5 Dec 2024
Amount $1.6300
10 Sept 2024
Amount $1.6300
10 Jun 2024
Amount $1.6300
7 Mar 2024
Amount $1.6300
5 Dec 2023
Amount $1.4800
7 Sept 2023
Amount $1.4800
8 Jun 2023
Amount $1.4800
9 Mar 2023
Amount $1.4800
2 Dec 2022
Amount $1.2800
8 Sept 2022
Amount $1.2800
9 Jun 2022
Amount $1.2800
9 Mar 2022
Amount $1.2800
2 Dec 2021
Amount $1.1300
9 Sept 2021
Amount $1.1300
9 Jun 2021
Amount $1.1300
9 Mar 2021
Amount $1.1300
4 Dec 2020
Amount $0.9500
9 Sept 2020
Amount $0.9500
9 Jun 2020
Amount $0.9500
13 Mar 2020
Amount $0.9500
4 Dec 2019
Amount $0.8000
9 Sept 2019
Amount $0.8000

Stock Splits

Split History

1 Jun 2005Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ANTM

Which members of Congress have traded ANTM?
8 members of Congress have disclosed 28 trades in Elevance Health Inc. (ANTM) under the STOCK Act. The most active traders are John Curtis, Lizzie Fletcher, and Joe Courtney.
When was ANTM most recently disclosed by Congress?
The most recent ANTM disclosure was a sale by John Curtis on 9 March 2022.
What is the total disclosed congressional trading volume for ANTM?
Members of Congress have disclosed approximately $120K in ANTM purchases and $279K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ANTM?
This ANTM page updates as soon as new STOCK Act disclosures are filed for Elevance Health Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.